Table of Content
1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 19
1.2.1 MARKETS COVERED 20
1.2.2 YEARS CONSIDERED FOR THE STUDY 20
1.3 CURRENCY 21
1.4 LIMITATIONS 21
1.5 STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH APPROACH 22
2.1.1 SECONDARY RESEARCH 23
2.1.1.1 Key data from secondary sources 23
2.1.2 PRIMARY RESEARCH 24
2.1.2.1 Key data from primary sources 24
2.1.2.2 Breakdown of primaries 25
2.2 MARKET SIZE ESTIMATION 25
2.2.1 TOP-DOWN APPROACH 26
2.2.2 GROWTH FORECAST 26
2.3 DATA TRIANGULATION APPROACH 28
2.4 MARKET SHARE ESTIMATION 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 35
4.1 CLINICAL-GRADE WEARABLES MARKET OVERVIEW 35
4.2 APAC CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 36
4.3 GEOGRAPHIC SNAPSHOT OF THE CLINICAL-GRADE WEARABLES MARKET 37
4.4 REGIONAL MIX:CLINICAL-GRADE WEARABLES MARKET 38
4.5 CLINICAL-GRADE WEARABLES MARKET: DEVELOPING VS. DEVELOPED MARKETS 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 DRIVERS 41
5.2.1.1 Increasing awareness of fitness and incidence of lifestyle disorders 41
5.2.1.2 Advent of technologically advanced products 41
5.2.1.3 Growing geriatric population and incidence of chronic diseases 42
5.2.1.4 Cost-containment in healthcare delivery 42
5.2.1.5 Robust penetration of 3G and 4G networks for uninterrupted healthcare services 42
5.2.2 RESTRAINTS 43
5.2.2.1 Unfavorable standards and regulations 43
5.2.2.2 Accuracy, standardization, and analysis of wearable-generated data 43
5.2.3 OPPORTUNITIES 44
5.2.3.1 Growing adoption of mobile platforms 44
5.2.3.2 Increasing adoption of AI and 5G 44
5.2.4 CHALLENGES 44
5.2.4.1 Patent protection of clinical-grade wearables 44
5.2.4.2 Lack of data security and concerns over data theft and healthcare fraud 45
5.2.4.3 Limited battery life 45
5.2.4.4 Device design complexity 45
6 INDUSTRY INSIGHTS 46
6.1 INDUSTRY TRENDS 46
6.2 ONCOLOGY - THE NEXT FRONTIER FOR CLINICAL-GRADE WEARABLES 46
6.3 FUTURE TRENDS IN CLINICAL-GRADE WEARABLES 46
6.4 INVESTMENTS IN CLINICAL-GRADE WEARABLE STARTUPS 47
7 CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 48
7.1 INTRODUCTION 49
7.2 VITAL SIGN MONITORING DEVICES 49
7.2.1 MULTIPARAMETER TRACKERS 51
7.2.1.1 Increase in the prevalence of chronic diseases to drive this market segment 51
7.2.2 ECG/HOLTER/HEART RATE MONITORS 52
7.2.2.1 ECG monitors help improve the quality of care by facilitating the continuous monitoring of patients?a key factor driving market growth 52
7.2.3 BLOOD PRESSURE MONITORS 54
7.2.3.1 Clinical-grade wearable blood pressure monitors form a popular category as these devices are convenient to use and relatively less expensive 54
7.2.4 PULSE OXIMETERS 56
7.2.4.1 Growing adoption of pulse oximeters for self-monitoring purposes to drive growth in this market segment 56
7.3 GLUCOSE MONITORING DEVICES & INSULIN PUMPS 57
7.3.1 GROWTH IN THE NUMBER OF DIABETICS PROPELS THE ADOPTION OF BLOOD GLUCOSE MONITORING DEVICES 57
7.4 FETAL MONITORING & OBSTETRIC DEVICES 59
7.4.1 RISE IN THE NUMBER OF PRETERM BIRTHS TO DRIVE THIS SEGMENT 59
_
7.5 NEUROMONITORING DEVICES 60
7.5.1 GROWING PREVALENCE OF NEUROLOGICAL DISEASES TO DRIVE THIS SEGMENT 60
7.6 SLEEP MONITORING DEVICES 62
7.6.1 CONTINUOUS MONITORING OF SLEEP PATTERNS HELPS IDENTIFY THE ROOT CAUSE OF SLEEP-RELATED DISORDERS, THEREBY AIDING PROPER DISEASE MANAGEMENT 62
8 CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 64
8.1 INTRODUCTION 65
8.2 PATCHES 65
8.2.1 EASE OF USE, CONVENIENCE, NON-INVASIVENESS, AND COMPACT DESIGN ARE EXPECTED TO DRIVE THE GROWTH OF THIS SEGMENT 65
8.3 SMARTWATCHES 67
8.3.1 DATA ACCURACY, LIMITED BATTERY LIFE, AND COMPETITION FROM FITNESS BANDS MAY LIMIT MARKET GROWTH TO A CERTAIN EXTENT 67
8.4 ACTIVITY MONITORS & WRISTBANDS 68
8.4.1 INCREASING PREVALENCE OF CHRONIC DISEASES HAS RESULTED IN A SIGNIFICANT INCREASE IN THE DEMAND FOR ACTIVITY MONITORS 68
8.5 OTHER CLINICAL-GRADE WEARABLES 70
9 CLINICAL-GRADE WEARABLES MARKET, BY END USER 72
9.1 INTRODUCTION 73
9.2 LONG-TERM CARE CENTERS, ASSISTED-LIVING FACILITIES, AND NURSING HOMES 73
9.2.1 INCREASING NUMBER OF PEOPLE REQUIRING LONG-TERM CARE AS A RESULT OF THE RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH 73
9.3 HOSPITALS 74
9.3.1 LEADING HOSPITALS ARE USING WEARABLE TECHNOLOGIES TO TRANSFORM RESIDENT TRAINING AND EMERGENCY MEDICINE COMMUNICATION, WHICH PROVIDES THEM WITH A CRITICAL ADVANTAGE 74
9.4 AMBULATORY CARE CENTERS 75
9.4.1 THE SHIFT OF PATIENT CARE FROM INPATIENT TO OUTPATIENT SETTINGS IS DRIVING THE GROWTH OF THIS END USER SEGMENT 75
9.5 HOME CARE SETTINGS 77
9.5.1 GOVERNMENT INITIATIVES ARE EXPECTED TO SUPPORT THE MARKET GROWTH 77
10 CLINICAL-GRADE WEARABLES MARKET, BY REGION 78
10.1 INTRODUCTION 79
10.2 NORTH AMERICA 80
10.2.1 US 83
10.2.1.1 In 2019, the US accounted for the largest share of the clinical-grade wearables market in North America 83
10.2.2 CANADA 85
10.2.2.1 Need to curtail escalating healthcare costs to drive the market in Canada 85
10.3 EUROPE 88
10.3.1 GERMANY 90
10.3.1.1 Need for better and improved healthcare services will drive the adoption of clinical-grade wearables in Germany 90
10.3.2 UK 93
10.3.2.1 Clinical-grade wearable devices have witnessed high penetration in the UK 93
10.3.3 FRANCE 95
10.3.3.1 Use of telehealth solutions and services through big data to propel market growth 95
10.3.4 ITALY 97
10.3.4.1 Increasing government initiatives for the implementation of eHealth technologies to support market growth 97
10.3.5 SPAIN 99
10.3.5.1 Spain has one of the highest levels of mobile phone penetration in Europe 99
10.3.6 REST OF EUROPE (ROE) 102
10.4 ASIA PACIFIC 104
10.4.1 JAPAN 107
10.4.1.1 Japan is a highly developed market for wireless technologies with a rapidly evolving mobile healthcare sector 107
10.4.2 CHINA 109
10.4.2.1 Growing focus of public & private players on clinical-grade wearables deployment in China to drive market growth 109
10.4.3 INDIA 112
10.4.3.1 Increasing number of initiatives from both government organizations and private players to improve access to healthcare to drive market growth 112
10.4.4 REST OF ASIA PACIFIC 114
10.5 LATIN AMERICA 116
10.5.1 INCREASE IN THE ADOPTION OF MOBILITY SOLUTIONS IN BRAZIL AND MEXICO TO DRIVE GROWTH IN THE CLINICAL-GRADE WEARABLES MARKET 116
10.6 MIDDLE EAST & AFRICA 118
10.6.1 GOVERNMENT INVESTMENTS IN BUILDING A HEALTHCARE MOBILITY FRAMEWORK IN THE MEA REGION TO DRIVE MARKET GROWTH 118
11 COMPETITIVE LANDSCAPE 120
11.1 OVERVIEW 120
11.2 MARKET RANKING ANALYSIS 121
11.3 COMPETITIVE LEADERSHIP MAPPING, 2018 122
11.3.1 VISIONARY LEADERS 122
11.3.2 INNOVATORS 122
11.3.3 EMERGING COMPANIES 122
11.3.4 DYNAMIC DIFFERENTIATORS 122
_
11.4 COMPETITIVE SITUATION AND TRENDS 124
11.4.1 NEW PRODUCT LAUNCHES & ENHANCEMENTS 124
11.4.2 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS 125
11.4.3 ACQUISITIONS 126
12 COMPANY PROFILES 127
(Business overview, Products offered, Recent developments & MnM View)*
12.1 KONINKLIJKE PHILIPS N.V. 127
12.2 MEDTRONIC PLC 130
12.3 OMRON HEALTHCARE CO., LTD. (A PART OF OMRON CORPORATION) 133
12.4 BIOTELEMETRY, INC. 135
12.5 APPLE, INC. 137
12.6 GE HEALTHCARE 139
12.7 ABBOTT LABORATORIES 141
12.8 DEXCOM, INC. 143
12.9 IRHYTHM TECHNOLOGIES, INC. 145
12.10 MASIMO CORPORATION 146
12.11 PREVENTICE SOLUTIONS, INC. 147
12.12 CONTEC MEDICAL SYSTEMS CO. LTD. 148
12.13 BIO-BEAT TECHNOLOGIES 149
12.14 VITALCONNECT 150
12.15 MINTTIHEALTH 151
12.16 BIOTRICITY INC. 152
12.17 VERILY LIFE SCIENCES (A PART OF ALPHABET INC.) 152
12.18 CYRCARDIA ASIA LIMITED 152
12.19 TEN3T HEALTHCARE 153
12.20 VIVALNK, INC. 153
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13 APPENDIX 154
13.1 INSIGHTS FROM INDUSTRY EXPERTS 154
13.2 DISCUSSION GUIDE 155
13.4 RELATED REPORTS 161
13.5 AUTHOR DETAILS 162
List of Figures
FIGURE 1 CLINICAL-GRADE WEARABLES MARKET SEGMENTATION 20
FIGURE 2 RESEARCH DESIGN 22
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION 25
FIGURE 4 MARKET SIZE APPROACH 1 26
FIGURE 5 MARKET SIZE APPROACH 2 27
FIGURE 6 TOP-DOWN APPROACH 27
FIGURE 7 DATA TRIANGULATION METHODOLOGY 28
FIGURE 8 CLINICAL-GRADE WEARABLES BY DEVICE TYPE, 2020 VS. 2025 (USD BILLION) 31
FIGURE 9 VITAL SIGNS MONITORING MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 31
FIGURE 10 CLINICAL-GRADE WEARABLES MARKET, BY END USER 2020 VS. 2025 (USD BILLION) 32
FIGURE 11 CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2020 VS. 2025 (USD BILLION) 33
FIGURE 12 CLINICAL-GRADE WEARABLES MARKET: REGIONAL SNAPSHOT 34
FIGURE 13 INCREASING GERIATRIC POPULATION AND RISING FOCUS ON PATIENT CENTRIC HEALTHCARE DELIVERY TO DRIVE MARKET GROWTH 35
FIGURE 14 PATCHES COMMANDED THE LARGEST SHARE OF THE APAC PRODUCT
MARKET IN 2019 36
FIGURE 15 MARKET IN JAPAN TO GROW AT THE HIGHEST CAGR DURING
THE FORECAST PERIOD 37
FIGURE 16 ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 38
FIGURE 17 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING
THE FORECAST PERIOD 39
FIGURE 18 CLINICAL-GRADE WEARABLES DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 40
FIGURE 19 GEOGRAPHIC SNAPSHOT OF THE CLINICAL-GRADE WEARABLES MARKET 79
FIGURE 20 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET SNAPSHOT 81
FIGURE 21 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET SNAPSHOT 105
FIGURE 22 PRODUCT LAUNCHES?KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM 2017 TO JANUARY 2020 120
FIGURE 23 CLINICAL GRADE WEARABLES MARKET RANKING ANALYSIS, BY PLAYER, 2019 121
FIGURE 24 CLINICAL GRADE WEARBLES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2018 123
FIGURE 25 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019) 127
FIGURE 26 MEDTRONIC PLC: COMPANY SNAPSHOT (2019) 130
FIGURE 27 OMRON HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2018) 133
FIGURE 28 BIOTELEMETRY, INC.: COMPANY SNAPSHOT (2018) 135
FIGURE 29 APPLE, INC.: COMPANY SNAPSHOT (2019) 137
FIGURE 30 GE HEALTHCARE: COMPANY SNAPSHOT (2019) 139
FIGURE 31 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 141
FIGURE 32 DEXCOM, INC.: COMPANY SNAPSHOT (2018) 143
FIGURE 33 IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2018) 145
FIGURE 34 MASIMO CORPORATION: COMPANY SNAPSHOT (2018) 146
List of Tables
TABLE 1 CLINICAL-GRADE WEARABLES MARKET SNAPSHOT 30
TABLE 2 MAJOR INVESTMENTS IN START-UP COMPANIES 47
TABLE 3 CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 49
TABLE 4 VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 50
TABLE 5 VITAL SIGN MONITORING DEVICES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 50
TABLE 6 MULTIPARAMETER TRACKERS OFFERED BY KEY MARKET PLAYERS 51
TABLE 7 MULTIPARAMETER TRACKERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 52
TABLE 8 ECG/HOLTER/HEART RATE MONITORS OFFERED BY KEY MARKET PLAYERS 53
TABLE 9 ECG/HOLTER/HEART RATE MONITORS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 54
TABLE 10 BLOOD PRESSURE MONITORS OFFERED BY KEY MARKET PLAYERS 55
TABLE 11 BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 55
TABLE 12 PULSE OXIMETERS OFFERED BY KEY MARKET PLAYERS 56
TABLE 13 PULSE OXIMETERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 57
TABLE 14 GLUCOSE MONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 58
TABLE 15 GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 58
TABLE 16 FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY KEY MARKET PLAYERS 59
TABLE 17 FETAL MONITORING & OBSTETRIC DEVICES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 60
TABLE 18 NEUROMONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 61
TABLE 19 NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 20 SLEEP MONITORING DEVICES OFFERED BY KEY MARKET PLAYERS 62
TABLE 21 SLEEP MONITORING DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 63
TABLE 22 CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 65
TABLE 23 CLINICAL-GRADE WEARABLE PATCHES BY KEY MARKET PLAYERS 65
TABLE 24 CLINICAL-GRADE WEARABLE PATCHES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 66
TABLE 25 CLINICAL-GRADE WEARABLE SMARTWATCHES BY KEY MARKET PLAYERS 67
TABLE 26 CLINICAL-GRADE WEARABLE SMARTWATCHES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 68
TABLE 27 CLINICAL-GRADE WEARABLE ACTIVITY MONITORS & WRISTBANDS BY KEY MARKET PLAYERS 69
TABLE 28 CLINICAL-GRADE WEARABLE ACTIVITY MONITORS & WRISTBANDS MARKET BY COUNTRY, 2018–2025 (USD MILLION) 69
TABLE 29 OTHER CLINICAL-GRADE WEARABLES BY KEY MARKET PLAYERS 70
TABLE 30 OTHER CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 71
TABLE 31 CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018–2025 (USD MILLION) 73
TABLE 32 CLINICAL-GRADE WEARABLES MARKET FOR LONG-TERM CARE CENTERS, ASSISTED-LIVING FACILITIES, AND NURSING HOMES, BY COUNTRY 2018–2025 (USD MILLION) 74
TABLE 33 CLINICAL-GRADE WEARABLES MARKET FOR HOSPITALS, BY COUNTRY 2018–2025 (USD MILLION) 75
TABLE 34 CLINICAL-GRADE WEARABLES MARKET FOR AMBULATORY CARE CENTERS BY COUNTRY, 2018–2025 (USD MILLION) 76
TABLE 35 CLINICAL-GRADE WEARABLES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2018–2025 (USD MILLION) 77
TABLE 37 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 81
TABLE 38 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 82
TABLE 39 NORTH AMERICA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 82
TABLE 40 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 82
TABLE 41 NORTH AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 83
TABLE 42 US: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 84
TABLE 43 US: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 84
TABLE 44 US: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 84
TABLE 45 US: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 85
TABLE 46 US: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 85
TABLE 47 CANADA: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE WEARABLES MARKET 86
TABLE 48 CANADA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 87
TABLE 49 CANADA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 87
TABLE 50 CANADA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 87
TABLE 51 CANADA: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 88
TABLE 52 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 89
TABLE 53 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 89
TABLE 54 EUROPE: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 89
TABLE 55 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 90
TABLE 56 EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 90
TABLE 57 GERMANY: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE
WEARABLES MARKET 91
TABLE 58 GERMANY: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 91
TABLE 59 GERMANY: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 92
TABLE 60 GERMANY: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 92
TABLE 61 GERMANY: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 92
TABLE 62 UK: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 93
TABLE 63 UK: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 94
TABLE 64 UK: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 94
TABLE 65 UK: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 94
TABLE 66 FRANCE: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE
WEARABLES MARKET 95
TABLE 67 FRANCE: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 96
TABLE 68 FRANCE: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 96
TABLE 69 FRANCE: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 96
TABLE 70 FRANCE: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 97
TABLE 71 ITALY: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE
WEARABLES MARKET 98
TABLE 72 ITALY: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 98
TABLE 73 ITALY: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 98
TABLE 74 ITALY: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 99
TABLE 75 ITALY: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 99
TABLE 76 SPAIN: HEALTHCARE IT INITIATIVES 100
TABLE 77 SPAIN: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE
WEARABLES MARKET 100
TABLE 78 SPAIN: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 101
TABLE 79 SPAIN: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 101
TABLE 80 SPAIN: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 101
TABLE 81 SPAIN: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 102
TABLE 82 REST OF EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 102
TABLE 83 REST OF EUROPE: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 103
TABLE 84 REST OF EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 103
TABLE 85 REST OF EUROPE: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 103
TABLE 86 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 106
TABLE 87 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 106
TABLE 88 ASIA PACIFIC: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 106
TABLE 89 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 107
TABLE 90 ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 107
TABLE 91 JAPAN: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE
WEARABLES MARKET 108
TABLE 92 JAPAN: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 108
TABLE 93 JAPAN: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 108
TABLE 94 JAPAN: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 109
TABLE 95 JAPAN: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 109
TABLE 96 CHINA: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE
WEARABLES MARKET 110
TABLE 97 CHINA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 110
TABLE 98 CHINA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 111
TABLE 99 CHINA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 111
TABLE 100 CHINA: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 111
TABLE 101 INDIA: MACROECONOMIC INDICATORS FOR THE CLINICAL-GRADE
WEARABLES MARKET 112
TABLE 102 INDIA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 113
TABLE 103 INDIA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 113
TABLE 104 INDIA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 113
TABLE 105 INDIA: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 114
TABLE 106 REST OF ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 115
TABLE 107 REST OF ASIA PACIFIC: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 115
TABLE 108 REST OF ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 115
TABLE 109 REST OF ASIA PACIFIC: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018–2025 (USD MILLION) 116
TABLE 110 LATIN AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE 2018–2025 (USD MILLION) 116
TABLE 111 LATIN AMERICA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 117
TABLE 112 LATIN AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT 2018–2025 (USD MILLION) 117
TABLE 113 LATIN AMERICA: CLINICAL-GRADE WEARABLES MARKET, BY END USER 2018–2025 (USD MILLION) 117
TABLE 114 MIDDLE EAST & AFRICA: CLINICAL-GRADE WEARABLES MARKET, BY DEVICE TYPE, 2018–2025 (USD MILLION) 118
TABLE 115 MIDDLE EAST & AFRICA: VITAL SIGN MONITORING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 119
TABLE 116 MIDDLE EAST & AFRICA: CLINICAL-GRADE WEARABLES MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 119
TABLE 117 MIDDLE EAST & AFRICA: CLINICAL-GRADE WEARABLES MARKET, BY END USER, 2018–2025 (USD MILLION) 119
TABLE 118 PRODUCT LAUNCHES AND ENHANCEMENTS (2019) 124
TABLE 119 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS (2019) 125
TABLE 120 ACQUISITIONS (2018 & 2019) 126